| Autor: |
M. Hayat, J.H. Meerwaldt, Jean-Marc Cosset, B. de Pauw, M J Burgers, José Thomas, R. Regnier, J. Lutsman-Marechal, D. Bron, E.M. Noordijk, A. Tanguy, E. van der Schueren, R. Somers, M. Tubiana, Michel Henry-Amar, M. Monconduit, Patrice Carde |
| Rok vydání: |
1990 |
| Předmět: |
|
| Zdroj: |
International Journal of Radiation Oncology*Biology*Physics. 19:1155-1157 |
| ISSN: |
0360-3016 |
| Popis: |
The risk of dying from different causes after Hodgkin's disease (HD) therapy has been quantified from a series of 1,449 patients with early stages included in four successive clinical trials conducted by the European Organization for Research and Treatment of Cancer (EORTC) Lymphoma Cooperative Group since 1963. Overall, 240 patients died and the 15-year survival rate was 69% whereas the expected rate was 95%. The standardized mortality ratio (SMR) technique was used to quantify excess deaths as a function of time since first therapy. At each interval, SMR was significantly increased, giving: 0–3 year, 8.86 ( p p p p p p |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
